These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 93375)

  • 1. Treatment of generalized scleroderma: updated results.
    Asboe-Hansen G
    Acta Derm Venereol; 1979; 59(5):465-7. PubMed ID: 93375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of generalized scleroderma with inhibitors of collagen synthesis.
    Asboe-Hansen G
    Int J Dermatol; 1982 Apr; 21(3):159-61. PubMed ID: 7085173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G
    Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma.
    Blumenkrantz N; Asboe-Hansen G
    Acta Derm Venereol; 1980; 60(1):39-43. PubMed ID: 6153832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of generalized scleroderma with connective tissue inhibitors].
    Asboe-Hansen G
    Ugeskr Laeger; 1976 May; 138(22):1325-9. PubMed ID: 1273949
    [No Abstract]   [Full Text] [Related]  

  • 6. Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?
    Hagdrup H; Serup J; Tvedegaard E
    Acta Derm Venereol; 1983; 63(5):447-9. PubMed ID: 6197850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New developments in the pathology, pathophysiology and therapy of systemic scleroderma].
    Asboe-Hansen G
    Hautarzt; 1980 Nov; 31(11):584-7. PubMed ID: 7451139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of progressive scleroderma. Collagen-like protein in progressive scleroderma under D-penicillamine therapy].
    Kreysel HW; Schlichting H; Kimmig J
    Fortschr Med; 1975 Nov; 93(32):1596-9. PubMed ID: 1220999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analysis of dermis and urine in generalized scleroderma.
    Blumenkrantz N; Asboe-Hansen G
    Acta Derm Venereol; 1980; 60(2):115-18. PubMed ID: 6155015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collagen metabolites in the urine in patients with generalized scleroderma].
    Ammitzbøll T; Asboe-Hansen G
    Ugeskr Laeger; 1984 May; 146(22):1622-5. PubMed ID: 6515771
    [No Abstract]   [Full Text] [Related]  

  • 13. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H; Tausch G; Eberl R
    Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue changes in systemic sclerosis and the use of D-penicillamine.
    Jayson MI
    Agents Actions Suppl; 1979; (5):149-57. PubMed ID: 294132
    [No Abstract]   [Full Text] [Related]  

  • 16. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
    Høyer H; Hvid-Jacobsen K; Weismann K
    Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma cerebritis, an unusual manifestation of progressive systemic sclerosis.
    Wise TN; Ginzler EM
    Dis Nerv Syst; 1975 Feb; 36(2):60-2. PubMed ID: 1116415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G
    Acta Med Acad Sci Hung; 1978; 35(3-4):201-11. PubMed ID: 756110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.
    Uitto J; Helin P; Rasmussen O; Lorenzen I
    Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma].
    Schulze E; Herrmann K; Haustein UF; Krusche U; Rothenburger I
    Dermatol Monatsschr; 1988; 174(11):661-6. PubMed ID: 3145222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.